Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
149.56
+0.44 (+0.30%)
Official Closing Price
Updated: 4:10 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
91
92
Next >
3 Stocks To Consider After Beating Earnings Estimates
January 23, 2024
With the earnings season now in full force, valuable data to gauge the broader economy will be rolling in. I will share three stocks that posted earnings beats this morning, and that I think may be...
Via
Talk Markets
Topics
Earnings
Economy
Exposures
Economy
Financial
Your Guide To Volatile Earnings This Week - NFLX On The Move
January 23, 2024
This week we get to play some earnings trades as earnings season begins for 2024. We're seeing Netflix rally immediately after hours on its earnings as we plot its expected move for tomorrow and...
Via
Talk Markets
Johnson & Johnson (JNJ) Q4 2023 Earnings Call Transcript
January 23, 2024
JNJ earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
US Stocks Pause As Treasury Yields, Dollar Surge On Trimmed Fed Rate Cut Bets: What's Driving Markets Tuesday?
January 23, 2024
Wall Street took a breather on Tuesday, with the major U.S. stock indices trading near the flatline or showing slight declines during midday trading in New York as investors closely await a series of...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Why Johnson & Johnson Stock Was Pulling Back Today
January 23, 2024
The healthcare giant matched estimates, but it wasn't enough to please investors.
Via
The Motley Fool
Johnson & Johnson's Settlement For Talc Cancer Lawsuits Reaches $700M Settlement With US States
January 23, 2024
Johnson & Johnson settles state investigations for $700 million, addressing alleged talc product safety issues linked to cancer.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
What's Going On With Danish Healthcare Firm Genmab Stock?
January 23, 2024
Genmab's legal update on Darzalex: Arbitrator dismisses bid for milestone payments. Despite this, diverse revenue sources, including royalty agreements, contribute to strong growth.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 23, 2024
Via
Benzinga
US Stocks Mixed; Johnson & Johnson Posts Upbeat Earnings
January 23, 2024
U.S. stocks traded mixed this morning, with the Dow Jones index falling around 90 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.23% to 37,915.41 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Johnson & Johnson's Clock 12% Q4 Revenue Growth, Cancer and Crohn's Disease Drugs Account as Largest Sellers
January 23, 2024
Johnson & Johnson's Q4 2023 performance, with adjusted earnings up 11.7%, sales at $21.4 billion, and key insights into pharmaceutical and MedTech segments.
Via
Benzinga
Why J&J's Narrow Fourth-Quarter Beat Is A Blessing For Medtech
January 23, 2024
The company's medtech sales easily beat expectations, which bodes well for medtech stocks.
Via
Investor's Business Daily
Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
January 23, 2024
In a significant development, the FDA is set to impose a classwide black box warning following its investigation into secondary T-cell cancers arising from the use of existing CAR-T therapies.
Via
Benzinga
Exposures
Product Safety
US Stocks Prepare For Nervy Start Ahead of Netflix, TI Earnings: Analyst Says Cash Waiting On Sidelines Could Flood Street If This Happens
January 23, 2024
The mood turned circumspect on Tuesday as traders digested a deluge of earnings reports and anticipated market-moving economic data for the week.
Via
Benzinga
Johnson & Johnson Surpasses $2.28 EPS Expectation in Q4
January 23, 2024
Johnson & Johnson exceeded the anticipated earnings per share (EPS) of $2.28, showcasing operational efficiency and resilience in a complex global business environment.
Via
Talk Markets
2 Genius Safe Stocks to Buy for 2024 and Beyond
January 23, 2024
These companies have considerable profits and tried-and-true dividends in common.
Via
The Motley Fool
Earnings Scheduled For January 23, 2024
January 23, 2024
Companies Reporting Before The Bell • Webster Finl (NYSE:WBS) is estimated to report quarterly earnings at $1.46 per share on revenue of $603.11 million.
Via
Benzinga
Fear & Greed Index Remains In 'Greed' Zone; Dow Settles Above 38,000
January 23, 2024
The CNN Money Fear and Greed index remained in the "Greed" zone on Monday. U.S. stocks closed higher on Monday, with the Dow Jones index settling above the 38,000 mark for the first time.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Verizon, Netflix And 3 Stocks To Watch Heading Into Tuesday
January 23, 2024
With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Dow Jones Stocks: From 3M To Intel, A Big Earnings Week For Blue Chips
January 22, 2024
Eight Dow Jones stock report earnings this week. Several, including Verizon and 3M, are in buy zones or near buy points.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
10 Health Care Stocks Whale Activity In Today's Session
January 22, 2024
Via
Benzinga
Johnson & Johnson Secures Complete FDA Approval For Bladder Cancer Drug Balversa, After Almost Five Years Of Accelerated Approval
January 22, 2024
FDA-approved Balversa for urothelial carcinoma treatment. The first oral FGFR kinase inhibitor offers clinical benefits, extended overall survival, and a breakthrough for FGFR alterations in metastatic...
Via
Benzinga
Exposures
Product Safety
S&P 500, Nasdaq, Dow Jones Strike All-Time Highs Ahead Of Key Earnings This Week: What's Driving Markets Monday?
January 22, 2024
US stocks rise to record highs on strong earnings reports, with small caps outperforming. Dollar steady, gold down, oil up. Bitcoin tumbles. AMD, TSLA, ADM, GILD, WDC top movers. GE, AAPL, FB, AMZN,...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Johnson & Johnson's Q4 Earnings: Spotlight On Dividend Security Following Kenvue Split, Legal Costs, Acquisitions
January 22, 2024
Johnson & Johnson (JNJ) to report Q4 earnings on Jan. 23, with expectations of $2.28 EPS and $20.99B revenue. Strong, diverse company with reliable dividend, but impacted by talc lawsuit settlement and...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Tesla, Netflix, Intel Take Center Stage In Pivotal Q4 Earnings Week As S&P 500 Eyes Breaking New Highs
January 22, 2024
According to Factset, the fourth-quarter earnings season has had a weak start, with the percentage of S&P 500 companies reporting positive earnings surprises below average.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
I'm Putting My Cash Stockpile to Work on These 3 Stocks
January 21, 2024
With the market selling off to start the year, this Fool plans to put some of his growing cash pile to work.
Via
The Motley Fool
Nearing Retirement? These Stocks Are as Safe as They Come
January 21, 2024
These stocks should provide solid income with little drama.
Via
The Motley Fool
Walgreens Boots Alliance Just Cut Its Dividend: Here Are 2 Companies That Won't
January 21, 2024
Not every dividend stock is created equal, and these two far exceed Walgreens Boots Alliance.
Via
The Motley Fool
My 5 Top Dividend Stocks to Buy Hand Over Fist in 2024
January 21, 2024
These stocks may help you win in 2024 -- no matter what the market does.
Via
The Motley Fool
3 High-Flying Stocks That Could Soar Even More in 2024
January 20, 2024
These big winners could keep the momentum going.
Via
The Motley Fool
Q4 Earnings Results Reflect Stability
January 19, 2024
We get into the heart of the Q4 earnings season this week, with more than 225 companies reporting results, including 71 S&P 500 members from various sectors and industries
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
91
92
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.